Issue 11, 2018

Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors

Abstract

A series of 13 phenyl substituted thiosemicarbazones (SB1–SB13) were synthesized and evaluated for their inhibitory potential towards human recombinant monoamine oxidase A and B (MAO-A and MAO-B, respectively) and acetylcholinesterase. The solid state structure of SB4 was ascertained by the single X-ray diffraction technique. Compounds SB5 and SB11 were potent for MAO-A (IC50 1.82 ± 0.14) and MAO-B (IC50 0.27 ± 0.015 μM), respectively. Furthermore, SB11 showed a high selectivity index (SI > 37.0) for MAO-B. The effects of fluorine orientation revealed that SB11 (m-fluorine) showed 28.2 times higher inhibitory activity than SB12 (o-fluorine) against MAO-B. Furthermore, inhibitions by SB5 and SB11 against MAO-A and MAO-B, respectively, were recovered to near reference levels in reversibility experiments. Both SB5 and SB11 showed competitive inhibition modes, with Ki values of 0.97 ± 0.042 and 0.12 ± 0.006 μM, respectively. These results indicate that SB5 and SB11 are selective, reversible and competitive inhibitors of MAO-A and MAO-B, respectively. Compounds SB5, SB7 and SB11 showed moderate inhibition against acetylcholinesterase with IC50 values of 35.35 ± 0.47, 15.61 ± 0.057 and 26.61 ± 0.338 μM, respectively. Blood–brain barrier (BBB) permeation was studied using the parallel artificial membrane permeation assay (PAMPA) method. Molecular docking studies were carried out using AutoDock 4.2.

Graphical abstract: Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors

Supplementary files

Article information

Article type
Research Article
Submitted
14 Aug 2018
Accepted
23 Sep 2018
First published
25 Sep 2018

Med. Chem. Commun., 2018,9, 1871-1881

Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors

B. Mathew, S. C. Baek, D. Grace Thomas Parambi, J. Pil Lee, M. Joy, P. R. Annie Rilda, R. V. Randev, P. Nithyamol, V. Vijayan, S. T. Inasu, G. E. Mathew, K. K. Lohidakshan, G. Kumar Krishnan and H. Kim, Med. Chem. Commun., 2018, 9, 1871 DOI: 10.1039/C8MD00399H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements